Metabolon Meta UDx

Metabolon launched the Meta UDx to help clinicians in the diagnosis of rare diseases, as well ailments in pediatric and adult patients that are difficult to diagnose. The test is analytically validated under CLIA as a laboratory-developed test and requires a small plasma sample. It looks for biomarkers or biochemical pathway changes that may indicate metabolic effects associated with diseases or disorders. Meta UDX surveys about 1,000 metabolites, Metabolon said.